about
4-Hydroxyisoleucine from Fenugreek (Trigonella foenum-graecum): Effects on Insulin Resistance Associated with ObesityAntiobesity pharmacotherapy: new drugs and emerging targetsCentral and peripheral molecular targets for antiobesity pharmacotherapy.Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity.Regulation of appetite to treat obesity.New advances in models and strategies for developing anti-obesity drugs.Obesity pharmacotherapy: what is next?Sizing up pharmacotherapy for obesityGenetic variations in the serotoninergic system contribute to body-mass index in Chinese adolescents.Gut-Brain Endocrine Axes in Weight Regulation and Obesity PharmacotherapyGUCY2C: at the intersection of obesity and cancerBrain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists.Anti-obesity drugs: past, present and future.New molecular targets in the pathophysiology of obesity and available treatment options under investigation.Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials.Editors' pick 2009.Editorial for BJCP Special Obesity Edition.Body mass index knowledge of older adults and motivation to change.Neural circuits of eating behaviour: Opportunities for therapeutic development.
P2860
Q28072896-8AD3E0F3-DFAB-4C34-B545-9338B0546BC0Q30354242-A30EBA00-A139-4636-9CB3-BB91C3E85122Q30388865-CF650B34-A164-4C72-8938-54D9C6A6AAECQ30399390-2A0CDE5D-033B-4FB7-B878-740B175E960BQ30403705-79288E42-5052-483B-B6EE-4AA79A499844Q30429816-E87A9E75-2090-4458-847B-E84FB6F56F7DQ33827988-CAD77831-BA5D-4EF2-879F-FDC0086BD395Q33969368-A07FF0FF-B1A7-4343-9964-DE8F843CD7DDQ34648230-CAB61970-0F51-486A-B6E1-44AD7EE7A801Q35667150-4D0808FE-95DF-4C09-B459-FB66253458A2Q36741685-700F43EF-4E89-4E8A-A1CA-6FD135512C9BQ37474214-B8D09085-122C-4EC5-B5D7-BC5488DFE228Q37865016-25E10354-80BB-49F0-8F83-B46F3159521CQ38036925-3FDC286F-3A44-4EFA-9FE1-8CDAA2D0DE04Q38397535-088B68FF-9C24-4A9D-9A01-7FC59347EC1AQ38848626-329C9ACB-3833-4701-A3F3-A442294387F0Q41819403-3F356AC7-730E-4F4D-99C5-DE6F268B4D45Q42931506-5AEF8A82-D122-46A3-B740-0A56EFEB07D0Q44264528-FEBDF012-D3A4-4B7C-BE59-1155D997FB34Q50046451-FE11D2C1-9595-4D9C-88C3-BA5CEDA6B357
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
New central targets for the treatment of obesity.
@ast
New central targets for the treatment of obesity.
@en
type
label
New central targets for the treatment of obesity.
@ast
New central targets for the treatment of obesity.
@en
prefLabel
New central targets for the treatment of obesity.
@ast
New central targets for the treatment of obesity.
@en
P2860
P1476
New central targets for the treatment of obesity.
@en
P2093
Bruce J Sargent
Nicholas A Moore
P2860
P304
P356
10.1111/J.1365-2125.2009.03550.X
P407
P577
2009-12-01T00:00:00Z